3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
OTHER_GOV
1
Study Type
Observational
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
4
Polycythemia Vera
3
Myeloproliferative Disorders
3
Stomach Neoplasms
2
Cardiovascular Diseases
2
Multiple Myeloma
1
Hemorrhage
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Barrett Esophagus
1
Adenomatous Polyps
1
Adenoma
1
Interventions
Capecitabine
77
pembrolizumab
70
Oxaliplatin
68
Cisplatin
56
Fluorouracil
52
Paclitaxel
41
Trastuzumab
37
Nivolumab
35
Leucovorin
27
Docetaxel
27
Irinotecan
22
Ramucirumab
20
Gemcitabine
15
Bevacizumab
15
S 1 (combination)
14
Carboplatin
13
atezolizumab
12
apatinib
12
fludarabine
11
Cyclophosphamide
11
tislelizumab
10
Drug Therapy
10
Injections
8
130-nm albumin-bound paclitaxel
8
trastuzumab deruxtecan
7
durvalumab
7
Ipilimumab
7
Folfox protocol
7
Albumin-Bound Paclitaxel
7
titanium silicide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Stomach Neoplasms
×
Aspirin
×
Clear all
NCT04081831
2022-04-19
ENgAGE-HK
Bayer
Completed
99,999 enrolled
NCT03743883
2020-06-01
ENgAGE-UK
Bayer
Completed
99,999 enrolled